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Abstract: Background We investigated changes in right atrial pressure (RAP) during exercise and their
prognostic significance in patients assessed for pulmonary hypertension (PH). Methods and Results Con-
secutive right heart catheterization data, including RAP recorded during supine, stepwise cycle exercise
in 270 patients evaluated for PH, were analyzed retrospectively and compared among groups of patients
with PH (mean pulmonary artery pressure [mPAP] ฀25 mm Hg), exercise-induced PH (exPH; resting
mPAP <25 mm Hg, exercise mPAP >30 mm Hg, and mPAP/cardiac output >3 Wood Units (WU)),
and without PH (noPH). We investigated RAP changes during exercise and survival over a median (quar-
tiles) observation period of 3.7 (2.8-5.6) years. In 152 patients with PH, 58 with exPH, and 60 with noPH,
median (quartiles) resting RAP was 8 (6-11), 6 (4-8), and 6 (4-8) mm Hg (P<0.005 for noPH and exPH
versus PH). Corresponding peak changes (95% CI) in RAP during exercise were 5 (4-6), 3 (2-4), and -1
(-2 to 0) mm Hg (noPH versus PH P<0.001, noPH versus exPH P=0.027). RAP increase during exercise
correlated with mPAP/cardiac output increase (r=0.528, P<0.001). The risk of death or lung transplan-
tation was higher in patients with exercise-induced RAP increase (hazard ratio, 4.24; 95% CI, 1.69-10.64;
P=0.002) compared with patients with unaltered or decreasing RAP during exercise. Conclusions In
patients evaluated for PH, RAP during exercise should not be assumed as constant. RAP increase during
exercise, as observed in exPH and PH, reflects hemodynamic impairment and poor prognosis. Therefore,
our data suggest that changes in RAP during exercise right heart catheterization are clinically important
indexes of the cardiovascular function.
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ORIGINAL RESEARCH
Right Atrial Pressure During Exercise 
Predicts Survival in Patients With Pulmonary 
Hypertension
Mona Lichtblau , MD*; Patrick R. Bader, MD*; Stéphanie Saxer, PhD*; Charlotte Berlier, MD; Esther I. Schwarz, MD; 
Elisabeth D. Hasler, MD; Michael Furian, PhD; Ekkehard Grünig, MD; Konrad E. Bloch, MD; Silvia Ulrich , MD
BACKGROUND: We investigated changes in right atrial pressure (RAP) during exercise and their prognostic significance in 
 patients assessed for pulmonary hypertension (PH).
METHODS AND RESULTS: Consecutive right heart catheterization data, including RAP recorded during supine, stepwise cycle 
exercise in 270 patients evaluated for PH, were analyzed retrospectively and compared among groups of patients with PH 
(mean pulmonary artery pressure [mPAP] ≥25 mm Hg), exercise-induced PH (exPH; resting mPAP <25 mm Hg, exercise 
mPAP >30 mm Hg, and mPAP/cardiac output >3 Wood Units (WU)), and without PH (noPH). We investigated RAP changes 
during exercise and survival over a median (quartiles) observation period of 3.7 (2.8–5.6) years. In 152 patients with PH, 58 
with exPH, and 60 with noPH, median (quartiles) resting RAP was 8 (6–11), 6 (4–8), and 6 (4–8) mm Hg (P<0.005 for noPH 
and exPH versus PH). Corresponding peak changes (95% CI) in RAP during exercise were 5 (4–6), 3 (2–4), and −1 (−2 to 0) 
mm Hg (noPH versus PH P<0.001, noPH versus exPH P=0.027). RAP increase during exercise correlated with mPAP/cardiac 
output increase (r=0.528, P<0.001). The risk of death or lung transplantation was higher in patients with exercise-induced RAP 
increase (hazard ratio, 4.24; 95% CI, 1.69–10.64; P=0.002) compared with patients with unaltered or decreasing RAP during 
exercise.
CONCLUSIONS: In patients evaluated for PH, RAP during exercise should not be assumed as constant. RAP increase during 
exercise, as observed in exPH and PH, reflects hemodynamic impairment and poor prognosis. Therefore, our data suggest 
that changes in RAP during exercise right heart catheterization are clinically important indexes of the cardiovascular function.
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I
n the absence of obstruction of the vena cava, cen-
tral venous pressure and right atrial pressure (RAP) 
are identical and reflect right ventricular preload. The 
gold standard to assess RAP is an invasive measure-
ment via a central venous line. Normal RAP at rest is 
between 1 and 7  mm  Hg.1 An elevated resting RAP 
is associated with a poor prognosis in a broad spec-
trum of cardiovascular disorders, including chronic 
heart failure and precapillary pulmonary hypertension 
(PH).2-5 Little is known about the course of the RAP 
during exercise in healthy subjects and patients with 
PH. In a systematic review of the literature, Kovacs et 
al assembled the course of the mean pulmonary artery 
pressure (mPAP), cardiac output (CO), and pulmonary 
artery wedge pressure assessed during right heart 
catheterization (RHC). They included 47 publications 
describing 72 populations comprising 1187 subjects 
(≈1/5 women, 1/3 during exercise).6 However, this ex-
tensive review of the literature did not identify data on 
RAP during exercise. The RAP at rest is not only a 
prognostic factor, but is also of importance for esti-
mating systolic pulmonary artery pressure (PAP) with 
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echocardiography as transtricuspid pressure gradi-
ent+RAP.7,8 Although the gold standard to assess RAP 
is invasive, echocardiographers all over the world es-
timate the RAP noninvasively by the size and collaps-
ibility of the inferior vena cava.9 However, the precision 
of this method is suboptimal, and it is difficult to use 
during exercise. Thus, systolic PAP estimated during 
exercise-echocardiography is usually calculated by 
assuming a constant RAP estimated at rest. As the 
course of the RAP during exercise in patients with sus-
pected PH is not known, it is also not known whether 
the assumption of a constant RAP during exercise is 
justified.
In light of these uncertainties, the aims of the pres-
ent retrospective study were as follows: First, the aim 
was to comprehensively analyze changes of the RAP 
during supine exercise RHC in patients diagnosed 
with PH, patients with exercise-induced PH, and pa-
tients without PH. Second, the aim was to investigate 
the prognostic significance of RAP at rest and during 
exercise.
METHODS
Study Design and Subjects
All patients undergoing supine incremental step-
wise cycle exercise RHC as part of the workup of 
suspected PH in the PH center of the University 
Hospital Zürich between 2008 and 2016 were eligi-
ble. The data of this study are available from the cor-
responding author on reasonable request. Patients 
were excluded if they had only resting RHC, had re-
peated RHC, or did not consent to have their data 
used. Patients were grouped into resting PH (PH; 
mPAP ≥25 mmHg), patients with exercise-induced 
PH (exPH; exercise mPAP >30 mmHg and mPAP/CO 
>3 Wood Units, no resting PH),10 and patients with-
out PH (noPH; PH was ruled out). Patients with PH 
were diagnosed and classified according to current 
guidelines,11 with an extensive diagnostic workup, in-
cluding medical history, clinical assessment, blood 
analysis, pulmonary function tests, ventilation/perfu-
sion lung scan, pulmonary computed tomography, 
and/or digital subtraction angiography, and grouped 
into pulmonary arterial hypertension (PAH), PH attrib-
utable to left heart or lung disease, chronic thrombo-
embolic PH, or multifactorial. Of all included patients, 
demographics, classification, specific medication, 
New York Heart Association functional class, the 
6-minute walk distance (6MWD) within 2  weeks of 
the RHC, and venous and arterial blood test results 
were retrieved. Follow-up data from regular visits 
every 3 to 6 months were analyzed until death or lung 
transplantation (defined as event) or until January 31, 
2018, in censored patients.
Ethics
All patients gave written informed consent to RHC and 
to have their data registered for scientific analysis. The 
study complies with the Declaration of Helsinki and 
was approved by the local ethical authorities (Business 
Administration System for Ethics Committees [BASEC] 
2016-01594).
Exercise RHC
Exercise RHC was performed on a supine cycle 
ergometer (TheraVital Ergometer; MedicaGMbH, 
Ravensburg, Germany) with a stepwise incremen-
tal protocol (increase by 10 W every 3  minutes) as 
previously described.12 A balloon-tipped, triple-lu-
men, fluid-filled 7.5 Fr Swan Ganz catheter (Baxter/
Edwards, Deerfield, IL) was placed via a jugular vein 
according to standard procedures. Transducers were 
CLINICAL PERSPECTIVE
What Is New?
• In patients with precapillary pulmonary hy-
pertension: right atrial pressure (RAP) during 
exercise is not constant, RAP increase during 
exercise reflects hemodynamic impairment, 
and RAP increase during exercise is associated 
with higher mortality.
What Are the Clinical Implications?
• RAP increase during exercise is a marker of 
poor prognosis.
• As RAP cannot be assumed to be constant dur-
ing exercise, right ventricular/right atrial gradient 
rather than systolic pulmonary artery pressure 
estimations should be reported during stress 
echocardiography.
Nonstandard Abbreviations and Acronyms
6MWD 6-minute walk distance
CO cardiac output
exPH exercise-induced pulmonary 
hypertension
PAH pulmonary arterial hypertension
mPAP mean pulmonary artery pressure
noPH without pulmonary hypertension
PAP pulmonary artery pressure
PH pulmonary hypertension
RAP right atrial pressure
RHC right heart catheterization
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set at the midthoracic level and zeroed to atmos-
pheric pressure.10,13 Pressure tracings of continuously 
and simultaneously assessed PAP and RAP on the 
hemodynamic monitor system (Dräger SA, Liebefeld, 
Switzerland) were averaged over several respiratory 
cycles after at least 15 minutes of rest and in the last 
30 seconds of every exercise step.10,12,14,15 The pul-
monary artery wedge pressure, CO measured by 
thermodilution, and arterial blood oxygenation and 
mixed venous blood oxygenation were assessed at 
rest and in the last minute of every exercise step. 
Cardiac index was calculated as CO/body surface 
area. Pulmonary vascular resistance was calculated 
as pulmonary vascular resistance=(mPAP-pulmo-
nary artery wedge pressure)/CO.
Data Presentation and Statistical Analysis
Data are presented as median (quartiles) according to 
nonnormality assessed by Shapiro-Wilk test for most 
variables and grouped by the 3 main hemodynamic 
categories (noPH, exPH, and PH). Continuous vari-
ables were compared by Mann-Whitney, Wilcoxon, or 
Kruskal-Wallis test, as appropriate. To assess the asso-
ciation of changes in RAP during exercise with survival, 
in a first step, Kaplan-Meier analysis with presence or 
absence of an exercise-induced increase in RAP as 
dichotomous predictor was performed. In a second 
step, the effect of changes in RAP on survival while 
adjusting for several potential explanatory variables 
was explored, using Cox proportional hazard regres-
sion of changes in RAP with baseline RAP, changes in 
heart rate with exercise, the hemodynamic diagnostic 
group, and age as explanatory variables.16 In further 
exploratory analyses, univariable and multivariable 
stepwise backward Cox regression models were fitted 
with clinical, resting, and exercise hemodynamic vari-
ables as predictors. Univariate and stepwise backward 
multivariate regression was used to correlate changes 
of the RAP with exercise with characteristics and key 
hemodynamic parameters. SPSS 25, Microsoft Excel, 
Graph-Pad, and Sigma plot were used. P<0.05 was 
considered significant.
RESULTS
Study Population and Hemodynamics 
During Exercise
Of 326 patients undergoing RHC during the study 
period, 270 patient data sets were included in the 
present analysis. A total of 12 patients did not have 
exercise RHC, 15 underwent a different exercise pro-
tocol, 17 did not give informed consent for further 
data analysis, and 12 were RHC follow-ups of pa-
tients already included in the analysis (Figure 1, study 
flow). Patient characteristics are shown in Table 1. 
The median observation time was 3.7 (2.8–5.6) years. 
Most patients were in New York Heart Association 
class II or III, with a median 6MWD of 468 (359–530) 
m. The median peak workload achieved was 40 (30–
50) W in noPH, 30 (20–40) W in exPH, and 20 (20–
30) W in PH, with significant differences between 
groups (Table 2). Patterns of main hemodynamic 
responses are illustrated in Figure 2. Although the 
RAP decreased or remained unchanged in patients 
with noPH, it increased during exercise in patients 
with PH and exPH, with the highest RAP at end ex-
ercise reached in patients with PH (Table 2, Figure 2). 
Figure 1. Patient flow.
RHC indicates right heart catheterizaton.
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mPAP significantly increased in all groups during 
exercise: the highest increase was found in PH, fol-
lowed by exPH (Table 2, Figure 2). Heart rate, stroke 
volume, and consequently CO and cardiac index 
increased with exercise in all groups, with a signifi-
cantly higher increase in noPH compared with PH 
or exPH (Table 2). The pressure/flow relationship, as 
assessed by mPAP/CO, did not significantly increase 
in noPH but increased in exPH and even more in PH. 
Of interest, the RAP/CO relationship significantly de-
creased in noPH, whereas it significantly increased in 
exPH and PH (Table 2).
Transplant-Free Survival
Kaplan-Meyer analysis indicates a >4-fold risk of 
death or lung transplantation (hazard ratio [HR], 4.24; 
95% CI, 1.69–10.64; P=0.002) (Figure 3) and a shorter 
transplant-free survival in patients with an exercise-
associated increase in RAP compared with patients 
with unaltered or decreasing RAP during exercise 
(7.0  years [95% CI, 6.5–7.5 years] versus 8.3  years 
[95% CI, 7.8–8.9 years]; P=0.002, log-rank test). In 
Cox regression, an exercise-induced increase in RAP 
remained a significant predictor of transplant-free 
survival even when age, resting RAP, heart rate, and 
diagnostic group (Table 3) were included as explana-
tory variables with known effect on outcome in the 
analysis.
To evaluate the association of various clinical, rest-
ing, and exercise hemodynamic variables with trans-
plant-free survival, various Cox regression models were 
fitted. They revealed that age, diagnostic group, New 
York Heart Association functional class, and the 6MWD 
were significant clinical predictors of transplant-free 
survival, with age and the 6MWD being the strongest 
significant predictors in the stepwise backward regres-
sion model (Table 4). With exception of RAP, resting 
hemodynamic variables were significant predictors in 
the univariate analysis, with heart rate and the arterial 
blood oxygenation remaining significant in the stepwise 
backward regression analysis (Table 4). Changes of he-
modynamic parameters during exercise were also uni-
variate predictors of transplant-free survival, whereas 
changes in arterial blood oxygenation were not statis-
tically significant. In the stepwise backward regression 
Table 1. Baseline Characteristics
Characteristics Overall noPH exPH PH
Subjects/women (%) 270/170 (63) 60/48 (80) 58/39 (67) 152/83 (55)
Age, y 62 (51–72) 53 (43–63) 63 (54–72) 67 (53–73)
Body mass index, kg/m2 25.4 (22.6–28.4) 24.2 (20.9–27.5) 25.6 (22.6–28.2) 25.5 (22.8–29.2)
Hemodynamic classification
noPH 60 (22) 60 (100)
exPH 58 (21) 58 (100)
PH 152 (57) 152 (100)
Pulmonary arterial hypertension 79 (29) 79 (52)
Idiopathic 52 (19) 52 (34)
Connective tissue diseases 20 (7) 20 (13)
HIV 1 (0) 1 (1)
Portopulmonary 5 (2) 5 (3)
PH associated with left heart disease 24 (9) 24 (16)
PH associated with lung disease 24 (9) 24 (16)
Chronic thromboembolic PH 23 (9) 23 (15)
Multifactorial 3 (1) 3 (2)
NYHA classification 3 (2–3) 2 (2–3) 2 (2–3) 3 (2–3)
I 21 (8) 10 (17) 4 (7) 7 (5)
II 92 (34) 23 (38) 31 (53) 38 (25)
III 109 (40) 19 (32) 17 (29) 73 (48)
IV 30 (11) 2 (3) 5 (9) 23 (15)
Not classified 18 (7) 6 (10) 1 (2) 11 (7)
NT-proBNP, ng/L 231 (94–752) 95 (41–194) 180 (80–446) 436 (141–1361)
Pulse oximetry at rest, % 93 (90–95) 95 (94–96) 94 (92–95) 91 (88–94)
6-min walking distance, m 468 (359–530) 512 (450–595) 498 (418–556) 437 (339–502)
Data are given as median (quartiles) or number (percentage). exPH indicates exercise-induced PH; noPH, without PH; NT-proBNP, N-terminal pro-B-type 
natriuretic peptide; NYHA, New York Heart Association; and PH, pulmonary hypertension. 
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model, only the change in RAP remained a significant 
predictor of transplant-free survival (HR, 1.085; 95% 
CI, 1.024–1.151; P=0.006; Table 4). Exercise-induced 
changes in RAP were significantly associated with 
several clinical and hemodynamic variables, and the 
mPAP/CO ratio was the best single predictor in step-
wise backward regression analysis (Table 5).
DISCUSSION
We assessed changes of the RAP during supine cy-
cling exercise in relation to various other hemodynamic 
and clinical outcomes in a large sample of patients as-
sessed for PH. The main novel findings of our investi-
gation are that changes in RAP during exercise were 
highly variable between individuals and differed be-
tween groups of patients without PH (noPH), showing 
an unchanged or decreasing RAP, and patients with PH 
at rest or during exercise (exPH or PH) in whom RAP 
increased with exercise (Figure 2). Most important, we 
found that the risk of death or lung transplantation was 
>4-fold elevated among patients with an RAP increase 
during exercise compared with the remaining patients 
(HR, 4.24; 95% CI, 1.69–10.4; Figure 3). Therefore, our 
data indicate that RAP during exercise should not be 
considered constant, and estimates of systolic PAP by 
echocardiography based on the transtricuspid pres-
sure gradient during exercise have to account for RAP 
Table 2. Hemodynamics at Rest and Stepwise Supine 
Cycling Exercise
Value/









Systolic blood pressure, mm Hg
noPH 123 (110–136) 150 (138–162)§ 23 (20 to 29)
exPH 124 (110–138) 165 (149–181)§ 34 (30 to 41)*
PH 129 (114–144) 160 (151–179)§ 28 (24 to 32)
Diastolic blood pressure, mm Hg
noPH 72 (66–79) 76 (65–87) 3 (−1 to 6)
exPH 72 (64–80) 81 (70–93)§ 8 (5 to 13)*
PH 78 (70–86) 87 (84–90)§ 10 (7 to 12)†
Heart rate, bpm
noPH 71 (67–79) 111 (100–125)§ 37 (33 to 42)
exPH 72 (62–79) 110 (97–124)§ 39 (33 to 44)
PH 77 (68–86)† 108 (97–117)†,§ 31 (27 to 33)†
Right atrial pressure, mm Hg
noPH 6 (4–8) 5 (3–8) -1 (−2 to 0)
exPH 6 (4–8) 9 (7–11)*,§ 3 (2 to 4)*
PH 8 (6–11)†, ‡ 13 (9–17)†,§,‡ 5 (4 to 6)†, ‡
Mean pulmonary artery pressure, mm Hg
noPH 16 (14–19) 25 (22–28)§ 8 (6 to 9)
exPH 21 (18–23)* 37 (33–41)*,§ 16 (15 to 19)*
PH 34 (29–43)† 54 (47–64)†,§,‡ 19 (17 to 20)†
Pulmonary artery wedge pressure, mm Hg
noPH 9 (5–13) 12 (8–16) 1 (0 to 4)
exPH 11 (9–13) 15 (12–18)§ 4 (2 to 6)*
PH 12 (9–15) 16 (12–20)§ 5 (4 to 6)†, ‡
Cardiac output, L/min
noPH 5.3 (4.1–6.5) 7.3 (5.9–8.4)§ 1.9 (1.5 to 2.3)
exPH 5.7 (4.7–6.7) 7.1 (5.8–8.4)§ 1.2 (0.9 to 1.8)*
PH 5.3 (4.2–6.4) 6.5 (5.0–8.0)§ 0.9 (0.7 to 1.1)†
Cardiac index, L/min per m2
noPH 3.0 (2.7–3.6) 4.2 (3.4–5.6)§ 1.1 (0.9 to 1.3)
exPH 3.0 (2.5–3.5) 4 (3.3–4.7)§ 0.7 (0.6 to 1.0)*
PH 2.9 (2.4–3.5) 3.6 (3.1–4.3)*, †, ‡ 0.5 (0.4 to 0.6)†
Pulmonary vascular resistance, Wood Units
noPH 1.2 (0.7–1.7) 1.6 (1.3–2.5)§ 0.3 (0.2 to 0.5)
exPH 1.6 (1.3–2.1)* 3.0 (2.9–3.5)*,§ 1.5 (1.4 to 1.6)*
PH 4.0 (2.7–6.1)† 5.4 (3.5–8)†,§,‡ 1.0 (0.9 to 1.5)†
SaO2, %
noPH 95 (95–97) 95 (94–96) -1 (−1 to 0)
exPH 94 (92–96) 94 (91–97) -2 (−3 to −1)
PH 91 (88–94) 90 (84–94)§ -3 (−4 to −2)†
 (Continued)
Value/






noPH 72 (68–78) 48 (35–61)§ -23 (−25 to −22)
exPH 70 (67–73) 41 (31–51)§ -29 (−34 to −24)
PH 66 (61–71) 37 (27–47)§ -29 (−31 to −27)†
RAP/cardiac output, Wood Units
noPH 1.2 (0.8–1.6) 0.6 (0.3–1.1)§ -0.4 (−0.6 to −0.2)
exPH 1.0 (0.6–13.1) 1.3 (0.9–1.7)*,§ 0.3 (0.1 to 0.5)*
PH 1.4 (0.9–2.2)† 2.0 (1.2–2.9)†,§,‡ 0.6 (0.4 to 0.8)†
mPAP/cardiac output, Wood Units
noPH 2.9 (2.1–3.7) 3.3 (2.4–4.2)§ 0.2 (−0.3 to 0.6)
exPH 3.4 (2.8–4.0)* 4.9 (3.5–6.3)*,§ 1.4 (1.3 to 2.0)*
PH 6.6 (4.6–8.8)† 8.4 (6.0–11.5)†,§,‡ 1.6 (1.4 to 1.9)†
Data are given as median (quartiles) and median change (95% CI). P<0.05 
in Kruskal-Wallis tests was followed by post hoc Mann-Whitney U tests. 
Bpm indicates beats per minute; exPH, exercise-induced PH; mPAP, mean 
pulmonary artery pressure; noPH, without PH; PH, pulmonary hypertension; 
RAP, right atrial pressure; SaO2, arterial oxygen saturation; and SmvO2, 
mixed venous oxygen saturation. 
*P<0.05 between noPH and exPH.
†P<0.05 between noPH and PH.
‡P<0.05 between exPH and PH.
§P<0.001 between rest and peak exercise.
Table 2. Continued
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changes. Our data suggest that changes in RAP are 
included into the assessment of the hemodynamic re-
sponse to exercise as they bear important physiologic 
and prognostic information.
Pulmonary hemodynamics during exercise have 
gained a lot of interest in recent years.10 Exercise 
PH may uncover early-stage pulmonary vascular 
disease, but may also occur in left heart disease, lung 
disease, or a combination of these conditions.10,17,18 
It has recently been reaccepted that an increase in 
mPAP >30 mm Hg along with an mPAP/CO of >3 WU 
serve as reasonable diagnostic criteria for exPH,18 
and this definition was also used in the present co-
hort. Besides hemodynamics during exercise being 
Figure 2. Patterns of hemodynamic responses recorded by right heart catheter during exercise tests.
Left upper panel: mean pulmonary artery pressure (mPAP) vs cardiac index (CI); right upper panel: CI 
vs right atrial pressure (RAP). Left lower panel: heart rate vs CI; right lower panel: mixed venous oxygen 
saturation (SmvO2) vs CI. The lines connect median values of variables at rest (symbols) with maximal 
values at end exercise (arrowheads). In patients without pulmonary hypertension (noPH), highest CI 
values were achieved with only minimal increase in mPAP and no increase in RAP and were associated 
with higher SmvO2. In contrast, in patients with pulmonary hypertension (PH), there is a major increase in 
mPAP and in RAP but an only minor increase in CI but the highest decrease in SmvO2. Values of patients 
with exercise-induced pulmonary hypertension (exPH) fall in between the 2 extremes. All exercise-
induced within-group changes in CI, mPAP, RAP, and SmvO2 are significant at P<0.05, with exception of 
the nonsignificant decrease in RAP in noPH; all between-group differences of changes in CI, mPAP, and 
RAP are significant at P<0.05, with exception of the nonsignificant difference in changes in CI between 
PH and exPH; PH additionally revealed significantly lower heart increase and higher decrease in SmvO2 
vs noPH, but not vs exPH. Numerical values are listed in Table 2.
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of importance to detect potentially latent and early 
pulmonary vascular diseases, especially in patients at 
risk, exercise hemodynamics also have a prognostic 
implication in patients diagnosed with PAH or distal 
chronic thromboembolic PH.12,19 We recently showed 
that patients with scleroderma with exPH have a sim-
ilarly impaired transplant-free survival as patients with 
scleroderma with PAH15 and that pressure/flow ra-
tios assessed during exercise predict transplant-free 
survival in patients with PAH or distal chronic throm-
boembolic PH.12 Hemodynamics during exercise are 
also increasingly used in the noninvasive assess-
ments of PH by echocardiography in the follow-up 
of patients with PH or as a screening tool for patients 
at risk, such as those with scleroderma, relatives 
of patients with PAH, or those at high altitude.20-22 
Echocardiographic assessment has been shown to 
correlate well with invasive hemodynamics if applied 
by experienced hands.23 However, there remain many 
questions about the normal and abnormal response 
to exercise in healthy subjects or patients at risk or 
with manifest PH.6,10
Figure 3. Kaplan-Meier analysis reveals a reduced transplant-free survival in patients with 
exercise-induced increase in right atrial pressure (RAP; ΔRAP with exercise >0 mm Hg, red line) 
compared with patients with a decrease or no change in RAP (ΔRAP with exercise ≤0 mm Hg, blue 
line). 
Table 3. Cox Regression Analysis of Predictors of Survival Without Lung Transplantation (With Focus on RAP)
Dependent Variable=Transplant-Free 
Survival





PLower Upper Lower Upper
Δ Right atrial pressure, mm Hg 1.113 1.061 1.167 <0.001 1.066 1.006 1.129 0.030
Right atrial pressure at rest, mm Hg 1.025 0.957 1.098 0.485
Δ Heart rate, bpm 1.324 1.158 1.514 <0.001
Age, y 1.053 1.028 1.078 <0.001 1.039 1.015 1.066 0.002
Group (noPH, reference PH) 0.193 0.069 0.542 0.002
Group (exPH, reference PH) 0.646 0.336 1.242 0.190
N=270. Δ Indicates change of variables with stepwise cycling exercise (peak exercise–rest). In multivariable stepwise backward regression, dependent 
variables with P<0.05 were maintained in the model; the final remaining step is shown. Bpm indicates beats per minute; exPH, exercise-induced PH; noPH, 
without PH; PH, pulmonary hypertension; and RAP, right atrial pressure. 
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The response of the RAP to exercise is not clear to 
date, possibly because of the fact that most patients 
assessed during exercise had more or less simulta-
neous assessments of PAP and CO, whereas RAP 
was often not available with commonly used Swan-
Ganz catheters that lack a separate atrial port. As 
we assessed a large group of 270 patients during 
supine cycling exercise, using RHC with a sepa-
rate port to simultaneously measure RAP with all 
above-mentioned hemodynamic measurements, our 
study provides a unique data set of comprehensive 
hemodynamic profiles. We found that, in patients 
with PH, most of them with PAH, the RAP increases 
with even slight exercise (on average only 20 W) by 
a median of 5 mm Hg and irrespective of diagnostic 
PH group (Table 2). This increase of the RAP in PH 
during mild exercise was higher compared with that 
of patients with exPH and much higher compared 
with that of patients evaluated for suspected PH but 
in whom the diagnosis was ruled out (Figure 2). RAP 
even slightly decreased during exercise in patients 
with normal hemodynamics (noPH). The reason for 
that cannot be conclusively unravelled. However, it 
might be speculated that the RAP decrease during 
exercise in patients without PH is related to the sta-
ble or even decreasing pulmonary vascular resis-
tance during exercise along with pulmonary artery 
distension and vessel recruitment and thus favorable 
ventriculoarterial coupling.24,25 The increase in RAP 
during progressive exercise in patients with PH and 
Table 4. Cox Regression Analyses of Predictors of Survival Without Lung Transplantation
Dependent Variable=Transplant-Free  
Survival
Univariable Analysis









PLower Upper Lower Upper
Clinical variables Age, y 1.053 1.028 1.078 <0.001 1.042 1.015 1.070 0.002
Sex (Men=0, Women=1) 1.681 0.995 2.841 0.052 0.589 0.332 1.044 0.070
BMI, kg/m2 0.938 0.890 0.989 0.014 0.926 0.874 0.981 0.009
Group (noPH, reference 
PH)
0.193 0.069 0.542 0.002
Group (exPH, reference 
PH)
0.646 0.336 1.242 0.190
NYHA class 2.164 1.521 3.081 <0.001
6MWD, m 0.995 0.993 0.997 <0.001 0.996 0.993 0.993 <0.001
Hemodynamics 
at rest
HR, bpm 1.036 1.015 1.058 0.001 1.031 1.009 1.053 0.006
RAP, mm Hg 1.025 0.957 1.098 0.485
mPAP, mm Hg 1.036 1.018 1.055 <0.001
CO, L/min 0.776 0.648 0.930 0.006 0.669 0.551 0.811 <0.001
PVR, WU 1.166 1.097 1.240 <0.001
mPAP/CO, mm Hg/L per 
min
1.141 1.082 1.203 <0.001
SaO2, % 0.908 0.871 0.946 <0.001 0.882 0.836 0.931 <0.001
SmvO2, % 0.908 0.880 0.938 <0.001
Δ in 
Hemodynamics 
from rest to peak 
exercise
ΔHR, bpm 0.979 0.963 0.995 0.010
ΔRAP, mm Hg 1.113 1.061 1.167 <0.001 1.116 1.062 1.172 <0.001
ΔmPAP, mm Hg 1.032 1.003 1.061 0.029
ΔCO, L/min 0.673 0.517 0.877 0.003
ΔPVR, WU 1.259 1.058 1.497 0.009
ΔmPAP/CO,WU 1.324 1.158 1.514 <0.001
ΔSpO2, % 0.987 0.973 1.001 0.090
ΔSmvO2, % 0.983 0.966 0.999 0.038
n = 270. In multivariable stepwise backward regression, dependent variables with P<0.05 were maintained, and variables with P≥0.1 were removed; the 
final step remaining is shown for each group. 6MWD indicates 6-minute walk distance; BMI, body mass index; bpm, beats per minute; CO, cardiac output; 
exPH, exercise-induced PH; HR, heart rate; mPAP, mean pulmonary artery pressure; no PH, without PH; NYHA, New York Heart Association; PH, pulmonary 
hypertension; PVR, pulmonary vascular resistance; RAP, right atrial pressure; SaO2, arterial oxygen saturation; SmvO2, mixed venous oxygen saturation; SpO2, 
arterial blood oxygenation; and WU, Wood Units.
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exPH may also reflect a reduced compliance and im-
pairment in right heart function that required higher 
filling pressures to increase the CO during exercise, 
whereas the more compliant healthy right ventricle in 
individuals with noPH may have accommodated the 
need for a greater oxygen delivery during exercise by 
increasing contractility in accordance with Guytons 
experiments in dogs, which showed that the venous 
return determines the CO (Figure 2).26,27 In addition, 
the greater exercise-induced decrease in mixed-ve-
nous oxygen saturation in PH compared with noPH 
reflects the requirement for greater oxygen extraction 
to compensate for the more advanced right ventric-
ular performance impairment that prevents an ade-
quate increase in CO (Figure 2).
The finding of a changing RAP during exercise 
might have the following clinical or research implica-
tions: The RAP is probably the easiest accessible in-
vasive hemodynamic index as it can be obtained by a 
simple, even peripherally inserted, central venous line. 
In the present series of 270 exercise RHC data sets, 
we found that the change of the RAP with exercise is 
correlated with the main hemodynamic measure in ex-
ercise RHC (namely, the mPAP/CO), and both RAP and 
mPAP behaved differently in patients with normal and 
impaired pulmonary circulation (Figure 2). To which ex-
tent assessment of the exercise RAP (eg, combined 
with cardiopulmonary exercise testing or stress-echo-
cardiography) would add in the diagnosis or follow-up 
of PH in general or where RHC is not readily available 
remains to be addressed by future, well-designed pro-
spective trials.
Another implication to be considered with the 
present finding of a changing RAP with exercise is 
the assessment by echocardiography. As the RAP 
estimated noninvasively by echocardiography based 
on the collapsibility of the vena cava or jugular vein 
distension is not reliable during exercise, it seems 
wise to report the tricuspid pressure gradient only 
instead of additionally indicating RAP, as already 
suggested by experts.23
Of interest, we found that patients demonstrating 
a decrease or no change in RAP during exercise have 
a significantly better transplant-free survival compared 
with patients with an increase in RAP during exercise 
in whom the risk of an unfavourable outcome was >4-
fold greater (Figure 3). Univariable Cox regression anal-
yses identified various other clinical and hemodynamic 
predictors of transplant-free survival (Table 5). Only the 
age, 6MWD, heart rate, and arterial blood oxygenation 
at rest and the exercise-induced change in RAP were 
maintained in stepwise backward analyses, likely be-
cause of multiple dependencies between several vari-
ables. In previous analyses of registries and cohorts, 
resting RAP was associated with prognosis,28 whereas 
this was not observed in the current study. Potential 
explanations are differences in patient groups, in par-
ticular, inclusion of patients with noPH and patients 
with PH in various risk classes in the current study, 
time point of assessment (ie, untreated baseline con-
dition versus over the course of treatment), and differ-
ences in the statistical approach, such as stratified or 
continuous analyses.29-31
Limitations of our study are the retrospective de-
sign and that all patients were assessed during su-
pine cycle ergometry. We do, thus, not know whether 
the changes in RAP and other hemodynamics would 
have been comparable if exercise would have been 
performed in another body position or on a treadmill. 
According to standards of RHC in clinical practice, 
vascular pressures were referenced to atmosphere, 
thus integrating intrathoracic pressure changes that 
vary during exercise in particular in chronic obstruc-
tive pulmonary disease with dynamic hyperinflation. 
This limitation applied to RAP as well as to mPAP and 
pulmonary artery wedge pressure but did not conceal 
the significant association of hemodynamics with 
prognosis. However, in this cohort, only a minority of 
Table 5. Regression Analysis of Exercise-Induced Changes in RAP and Other Variables
Dependent Variable=Δ RAP 
During Exercise
Univariable Analysis Stepwise Backward Regression Model
Coefficient 95% CI P Coefficient 95% CI P
Sex (men=0, women=1) −2.135 −3.357 to −0.951 0.001
Age, y 0.129 0.092 to 0.166 <0.001
Group (noPH, exPH, or PH) 0.544 0.279 to 0.809 <0.001
RAP at rest, mm Hg 0.219 0.058 to 0.380 0.008
ΔmPAP, mm Hg 0.249 0.185 to 0.312 <0.001
ΔPVR, WU 1.287 0.86 to 1.713 <0.001
ΔmPAP/CO, WU 1.472 1.173 to 1.770 <0.001 1.463 1.157 to 1.769 <0.001
n = 270. R2 of the final model was 0.257, P < 0.001. Δ Indicates change of parameters with stepwise cycling exercise (peak exercise–rest). CO indicates 
cardiac output; exPH, exercise-induced PH; mPAP, mean pulmonary artery pressure; noPH, without PH; PH, pulmonary hypertension; PVR, pulmonary 
vascular resistance; RAP, right atrial pressure; and WU, Wood Units.
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patients experienced chronic obstructive pulmonary 
disease. The average workload achieved in our large 
collective is relatively low; however, most patients 
experienced PH and were assessed supine, which 
is known to be associated with a reduced exercise 
capacity.32 Our noPH group consisted of patients 
who were evaluated by RHC because of suspected 
PH. Thus, these patients were not healthy, but ex-
perienced dyspnea or were at risk of PH. However, 
we would assume that healthy subjects would de-
crease their pulmonary vascular resistance and RAP 
even more with exercise, although this is not known 
to date.
In conclusion, this analysis of RAP recorded simul-
taneously with standard hemodynamics during exer-
cise RHC shows that the RAP cannot be assumed to 
remain constant during exercise. RAP increases in all 
PH groups even during mild exercise, but decreases 
or remains constant in dyspneic patients without PH. 
The exercise-induced change in RAP correlates well 
with other relevant exercise hemodynamic parame-
ters, including the pressure-flow relationship (mPAP/
CO), and it is an independent predictor of trans-
plant-free survival. Therefore, the exercise-induced 
change in RAP should be considered in the diagno-
sis and management of dyspneic patients with and 
without PH.
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